載入...
New antiviral therapies for chronic hepatitis C
Chronic hepatitis C is an important health issue worldwide. The current standard therapy is based on a combination of pegylated-interferon (pegIFN) and ribavirin (RBV), but this treatment leads to only ~50% sustained virological response (SVR) in patients with HCV genotype 1 and high viral loads, wh...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer-Verlag
2010
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2940000/ https://ncbi.nlm.nih.gov/pubmed/21063477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9193-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|